| Income Statement |
| Operating Expenses | 1.58M |
|
| Research and Development Expense | 2.95K |
| Selling, General and Administrative Expense | 1.39M |
| Operating Income | -1.58M |
| Net Income | -874.89K |
| Net Income Common Stock | -874.89K |
| Net Income Common Stock (USD) | -633.97K |
| Consolidated Income | -874.89K |
| Earning Before Interest & Taxes (EBIT) | -874.89K |
| Earning Before Interest & Taxes (USD) | -633.97K |
| Weighted Average Shares | 184.26M |
| Weighted Average Shares Diluted | 184.26M |
| Balance Sheet |
| Cash and Equivalents | 39.86M |
| Cash and Equivalents (USD) | 28.89M |
| Trade and Non-Trade Receivables | 77.01K |
| Current Assets | 40.34M |
| Property, Plant & Equipment Net | 120.44M |
| Total Assets | 160.77M |
| Current Liabilities | 1.06M |
| Total Liabilities | 1.06M |
| Accumulated Retained Earnings (Deficit) | -81.61M |
| Accumulated Other Comprehensive Income | 8.20M |
| Shareholders Equity | 159.71M |
| Shareholders Equity (USD) | 115.73M |
| Assets Non-Current | 120.44M |
| Trade and Non-Trade Payables | 901.61K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 39.74K |
| Net Cash Flow from Financing | 503.74K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.68M |
| Capital Expenditure | -1.18M |
| Issuance (Purchase) of Equity Shares | 503.74K |
| Net Cash Flow from Investing | -1.13M |
| Net Cash Flow - Investment Acquisitions and Disposals | 44.00K |
| Net Cash Flow from Operations | -837.08K |
| Effect of Exchange Rate Changes on Cash | -215.78K |
| Share Based Compensation | 372.59K |